SRPT vs STRD · rev $1.90B vs rev $463.5M
Sarepta Therapeutics Inc (SRPT) versus MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock (STRD) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock (STRD) is a software - application company listed on NASDAQ.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported STRD revenue for 2024-12-31 was $463.5M. Net income was -$1.17B. Revenue was down 6.6% from 2023-12-31 to 2024-12-31. STRD currently screens at market cap $901.8M.
SRPT currently screens at market cap $2.34B. STRD currently screens at market cap $901.8M.
Not investment advice. Open the SRPT and STRD stock pages for the full models.
Not investment advice.